CRONOS GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.34 USD | +0.86% |
|
+0.43% | +11.96% |
| 27/06 | Cronos Group Inc. Brand Spinach®? Celebrates Summer with New Launches | CI |
| 21/06 | Cronos Group Inc. Elects Murray Garnick as Director | CI |
| Sales 2024 * | 14Cr 10Cr 858.49Cr | Sales 2025 * | 17Cr 12Cr 1.04TCr | Capitalization | 124.24Cr 91Cr 7.56TCr |
|---|---|---|---|---|---|
| Net income 2024 * | -1.2Cr -87.66L -73Cr | Net income 2025 * | 80L 58.44L 49Cr | EV / Sales 2024 * | 0.26 x |
| Net cash position 2024 * | 120.56Cr 88Cr 7.34TCr | Net cash position 2025 * | 121.66Cr 89Cr 7.4TCr | EV / Sales 2025 * | 0.15 x |
| P/E ratio 2024 * |
-119
x | P/E ratio 2025 * |
-464
x | Employees | 356 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cronos Group Inc.
More recommendations
More press releases
| 1 day | +0.86% | ||
| 1 week | +0.43% | ||
| Current month | -9.65% | ||
| 1 month | -11.36% | ||
| 3 months | -13.33% | ||
| 6 months | +15.27% | ||
| Current year | +11.96% |
1 week
2.25
2.41
1 month
2.252.66
Current year
1.893.14
1 year
1.643.14
3 years
1.649.09
5 years
1.6416.34
10 years
0.1725.10
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 37 | 06/15/06 | |
James Holm
DFI | Director of Finance/CFO | 41 | 14/22/14 |
Arye Weigensberg
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
James Rudyk
BRD | Director/Board Member | 57 | 01/18/01 |
Jason Adler
BRD | Director/Board Member | 52 | 12/16/12 |
| Chief Executive Officer | 37 | 06/15/06 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/24/27 | 2.34 | +0.86% | 2,250,300 |
| 26/24/26 | 2.32 | +2.20% | 660,251 |
| 25/24/25 | 2.27 | -1.73% | 868,037 |
| 24/24/24 | 2.31 | -0.86% | 1,084,265 |
| 21/24/21 | 2.33 | 0.00% | 896,903 |
Delayed Quote Nasdaq, June 28, 2024 at 01:30 am IST
More quotes
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Companyâs segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Companyâs international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Lord Jones are hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions is a line-up of premium ice water hash infused pre-rolls. Its PEACE NATURALS offers Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.
Sector
Pharmaceuticals
Calendar
08/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.25
CAD
Average target price
3.597
CAD
Spread / Average Target
+10.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.10% | 559.76Cr | |
| -33.42% | 353.05Cr | |
| -3.33% | 302.97Cr | |
| -26.20% | 258.15Cr | |
| -9.99% | 230.75Cr | |
| +40.09% | 185.97Cr | |
| +40.90% | 144.94Cr | |
| -12.94% | 142.82Cr | |
| +46.67% | 141.07Cr |
- Stock Market
- Equities
- CRON Stock
- CRON Stock
